Salix Coronary Plaque vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 75/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are highly comparable as both leverage AI and CCTA scans to aid in the diagnosis of coronary artery disease. Tool A focuses on detailed anatomical assessment of coronary plaque and stenosis, including high-risk features and calcifications. In contrast, Tool B provides a functional assessment of blood flow using computational fluid dynamics to generate FFRct values, helping to identify areas of significant narrowing and guide treatment strategies.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Artrya Salix Coronary Plaque provides near real-time assessment of coronary artery plaque and stenosis from CCTA scans, including detection and quantification of plaque, identification of high-risk plaque features, and calcium scoring. HeartFlow FFRct Analysis creates personalized 3D models of coronary arteries from CCTA scans to assess blood flow and provide FFRct values, aiding in the diagnosis of coronary artery disease.
Artrya Salix Coronary Plaque has a US CPT reimbursement rate of US$950 per assessment. HeartFlow FFRct Analysis has a CMS payment rate of $1,017 for 2025, with commercial payer rates varying.
Salix Coronary Plaque uses AI-enabled CCTA analysis to focus on anatomical plaque characteristics, stenosis assessment, and the identification of high-risk plaque features. FFRct utilizes AI and computational fluid dynamics to generate personalized 3D models and analyze blood flow, providing physiological FFRct values to assess narrowing.
Artrya Salix Coronary Plaque is designed to provide near real-time, point-of-care assessment. HeartFlow FFRct Analysis involves cloud-based processing of CCTA data, but a specific turnaround time is not explicitly stated.
Artrya Salix Coronary Plaque aids in the rapid and accurate diagnosis of coronary artery disease by detecting and quantifying plaque and identifying high-risk features. HeartFlow FFRct Analysis helps guide treatment strategies and revascularization decisions by analyzing blood flow and identifying areas of narrowing with FFRct values.
Artrya Salix Coronary Plaque is capable of identifying several high-risk plaque features. These include low-attenuation plaque, spotty calcification, positive remodeling, and the napkin-ring sign.